2025
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases
Butensky S, Bansal V, Su D, Waheed M, Nikiforchin A, Gomez-Mayorga J, Olecki E, Radomski S, Sun B, Turaga K, Gunderson C, Lacy J, Badgwell B, In H, Kennedy T, Yoon H, Greer J, Sundar R, Woo Y. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases. Annals Of Surgical Oncology 2025, 1-18. PMID: 40560499, DOI: 10.1245/s10434-025-17361-2.Peer-Reviewed Original ResearchSynchronous peritoneal metastasesCytoreductive surgeryPeritoneal metastasisConsensus guidelinesLow peritoneal carcinomatosis indexPeritoneal carcinomatosis indexManagement of gastric cancerMultidisciplinary preoperative assessmentLimited treatment optionsNon-surgical managementLevel of evidenceClinical management pathwaysDiagnostic laparoscopyRandomized Controlled TrialsSystemic therapySurvival benefitPreoperative assessmentDisease subsetsTreatment optionsClinical trialsGastric cancerPathway blockBurden of diseasePatientsBackgroundGastric cancerConsensus guideline for the management of gastric cancer with synchronous peritoneal metastases
Butensky S, Bansal V, Su D, Waheed M, Nikiforchin A, Gomez‐Mayorga J, Olecki E, Radomski S, Sun B, Turaga K, Gunderson C, Lacy J, Badgwell B, In H, Kennedy T, Yoon H, Greer J, Sundar R, Woo Y, Group P. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer 2025, 131: e35870. PMID: 40558029, DOI: 10.1002/cncr.35870.Peer-Reviewed Original ResearchConceptsSynchronous peritoneal metastasesManagement of gastric cancerPeritoneal metastasisGastric cancerCytoreductive surgeryConsensus guidelinesLow peritoneal carcinomatosis indexPeritoneal carcinomatosis indexMultidisciplinary preoperative assessmentLimited treatment optionsPatient's goals of careLevel of evidenceGoals of careClinical management pathwaysCytology-negativeCytology-positiveRandomized Controlled TrialsDiagnostic laparoscopySystemic therapySurvival benefitBurden of diseasePreoperative assessmentNonsurgical managementDisease subsetsTreatment optionsPatterns of sialyl-Lewis X expression predict gastric histopathology
Vargas N, Quiroga A, Chaves J, Bolaños H, Nalbantoglu I, Astaiza C, Wu Y, Sáenz J. Patterns of sialyl-Lewis X expression predict gastric histopathology. Diagnostic Pathology 2025, 20: 76. PMID: 40551130, PMCID: PMC12183862, DOI: 10.1186/s13000-025-01673-8.Peer-Reviewed Original ResearchConceptsChronic atrophic gastritisChronic non-atrophic gastritisGastric pathologyAssociated with chronic atrophic gastritisIntestinal metaplasiaProgression to gastric cancerSLex expressionPre-cancerous lesionsNon-atrophic gastritisGastric pre-cancerous lesionsHistological diagnosisPre-cancerous changesGlandular distributionAntrum biopsiesAdult patientsGastric corpusAtrophic gastritisChronic inflammationGastric cancerHistological markersHistological assessmentGastric histopathologyGastric epitheliumIntroductionGastric cancerBiopsyFish consumption and gastric cancer within the Stomach cancer Pooling (StoP) Project
Franchi C, Ardoino I, Mandelli S, Patel L, Pelucchi C, Bonzi R, Camargo M, Rabkin C, Liao L, Sinha R, Johnson K, Hu J, Zhang Z, Palli D, Ferraroni M, Negri E, Turati F, Yu G, Lunet N, Morais S, López-Carrillo L, Tsugane S, Hidaka A, Malekzadeh R, Zaridze D, Maximovitch D, Vioque J, Gonzalez-Palacios S, Ward M, Aragonés N, Castaño-Vinyals G, Curado M, Dias-Neto E, Hamada G, Hernández-Ramirez R, Pakseresht M, Pourfarzi F, Mu L, Lagiou A, Lagiou P, López-Cervantes M, Dolci A, Boccia S, Pastorino R, Boffetta P, D’Avanzo B, La Vecchia C. Fish consumption and gastric cancer within the Stomach cancer Pooling (StoP) Project. Scientific Reports 2025, 15: 13099. PMID: 40240417, PMCID: PMC12003686, DOI: 10.1038/s41598-025-96658-4.Peer-Reviewed Original ResearchConceptsRisk of gastric cancerCancer riskAssociated with gastric cancer riskFamily history of gastric cancerStomach cancer PoolingStomach cancer riskHistory of gastric cancerGastric cancer riskIncreased intake of fishBody mass indexCase-control studyIntake of fishGeographical differencesFish consumptionGastric cancerPooling ProjectFamily historyMass indexCancer deathCanned fish consumptionFish intakeEnergy intakeMeta-analysisIncreased intakeHelicobacter pylori infectionAdvancing the Evaluation and Management of CDH1-Associated Gastric Cancer.
Lerner B, Gupta S, Burke C, Kupfer S, Katona B, Grady W, Samadder J, Yurgelun M, Kelly K, Moreno Prats M, Joseph N, Idos G, Swanson B, Kieber-Emmons A, Weiss J, Llor X. Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer. Journal Of The National Comprehensive Cancer Network 2025, 23 PMID: 40203872, DOI: 10.6004/jnccn.2025.7006.Peer-Reviewed Original ResearchConceptsSignet ring cell carcinomaPathogenic variant carriersGastric cancerEndoscopic surveillanceTotal gastrectomyVariant carriersGermline pathogenic variant carriersBenefits of gastrectomyCDH1 pathogenic variantsRisk of gastric cancerAdvanced gastric cancerProphylactic total gastrectomyPathogenic germline variantsFollow-up periodCumulative lifetime riskEvidence-based recommendationsUpper endoscopyCell carcinomaGlobal health concernDetected signet ring cell carcinomasGermline variantsPathogenic variantsGastrectomyGastrectomy specimensAdvanced cancerGenomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Janjigian Y, Cecchini M, Shitara K, Enzinger P, Wainberg Z, Chau I, Satoh T, Lee J, Nebozhyn M, Loboda A, Kobie J, Vajdi A, Shih C, Cristescu R, Cao Z. Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies. JCO Precision Oncology 2025, 9: e2400456. PMID: 40117530, PMCID: PMC11949223, DOI: 10.1200/po-24-00456.Peer-Reviewed Original ResearchConceptsTumor mutational burdenHomologous recombination deficiencyMicrosatellite instability-highGenomic characteristicsChromosomal instabilityKEYNOTE-062Late-stage GCKEYNOTE-059KEYNOTE-061Molecular subtypesAsian originWhole-exome sequencingGastric cancerSubtype prevalenceEpstein-Barr virus-positiveHomologous recombination deficiency scoresPretreatment tumor samplesWES dataGene expression signaturesCancer Genome AtlasMicrosatellite instability-high subtypeRNA sequencingGenomic landscapeEarly-stage GCGenomic alterationsAssociations between colonization with Helicobacter pylori and risk of gastrointestinal tract cancers: An umbrella review of meta‐analyses
Prudente T, Mezaiko E, Oliva H, Yamamoto‐Silva F, de Freitas Silva B, Oliva I, Risch H. Associations between colonization with Helicobacter pylori and risk of gastrointestinal tract cancers: An umbrella review of meta‐analyses. European Journal Of Clinical Investigation 2025, 55: e14394. PMID: 39878420, DOI: 10.1111/eci.14394.Peer-Reviewed Original ResearchMeta-analysesUmbrella reviewUmbrella review of meta-analysesMeta-analyses of observational studiesHelicobacter pylori colonizationHigher quality primary studiesReview of meta-analysesCochrane Library of Systematic ReviewsAMSTAR 2 toolQuality primary studiesPrimary study overlapAssociated with EACPylori colonizationBiliary tractAssociated with biliary tractGastric cancerOesophageal squamous cell carcinomaSquamous cell carcinomaHelicobacter pyloriGI tract cancersGastrointestinal tract cancerPrimary studiesSystematic reviewCochrane LibraryObservational studyEnvironmental Protective and Risk Factors for Gastric Cancer: An Umbrella Review and Reanalysis of Meta-Analyses
Kim S, Kim M, Kwon Y, Min J, Alromi A, Kim J, Kim J, Shin J, Yon D, Chu Y, Park S. Environmental Protective and Risk Factors for Gastric Cancer: An Umbrella Review and Reanalysis of Meta-Analyses. Journal Of Gastric Cancer 2025, 25: 285-302. PMID: 40200873, PMCID: PMC11982512, DOI: 10.5230/jgc.2025.25.e16.Peer-Reviewed Original ResearchConceptsIncreased risk of GCRisk of GCGC riskSystematic reviewMeta-analysesIncreased riskGrading of RecommendationsHeavy alcohol consumptionUmbrella reviewGraded associationGastric cancerHabitual salt intakeDietary habitsAlcohol consumptionEffect estimatesCochrane DatabaseGC preventionGrain consumptionPositive associationReduced riskEnvironmental exposuresRisk factorsHuman T-lymphotropic virus type 1Salt intakeDietary intervention
2024
Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers
Lerner B, Giner-Calabuig M, Carraway C, Richardson M, Krahn K, Susswein L, Nielsen S, Karam R, Xicola R, Llor X. Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers. Journal Of Medical Genetics 2024, 62: 57-61. PMID: 39674581, PMCID: PMC11916899, DOI: 10.1136/jmg-2024-110446.Peer-Reviewed Original ResearchInternational Gastric Cancer Linkage ConsortiumInternational Gastric Cancer Linkage Consortium criteriaPV carriersLobular breast cancerGenetic tumor risk syndromesGenetic testingFamily membersEarly-onset diffuse gastric cancerPathogenic variant carriersGermline pathogenic variantsDiffuse gastric cancerPathogenic variantsEuropean Reference NetworkCancer geneticsRisk syndromeVariant carriersGenetics guidelinesEuropean cohortAutosomal-dominant syndromeBreast cancerCohortUS commercial laboratoryClinical dataGastric cancerCancerPer- and poly-fluoroalkyl substances exposure and risk of gastrointestinal cancers: a systematic review and meta-analysis.
Zhang S, Kappil E, Zheng T, Boffetta P, Seyyedsalehi M. Per- and poly-fluoroalkyl substances exposure and risk of gastrointestinal cancers: a systematic review and meta-analysis. European Journal Of Cancer Prevention 2024 PMID: 39648934, DOI: 10.1097/cej.0000000000000935.Peer-Reviewed Original ResearchPFAS exposureStratified analysisMeta-analysisRisk of gastrointestinal cancerSystematic reviewGastrointestinal cancerModified Newcastle-Ottawa ScaleInternational Agency for Research on Cancer MonographsNewcastle-Ottawa ScaleSystematic review of literatureDose-response trendRandom-effects modelPancreatic cancerPotential confoundersIndependent reviewersYear of publicationPublication biasStudy designMeta-analysesColorectal cancerGastric cancerQuality scoresColorectalSubstance exposurePoly-fluoroalkyl substancesGastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry
Yibrehu B, Mohammed T, Murthy S, Aderibigbe A, Daramola O, Arije O, Owoade I, Wuraola F, Olasehinde O, Betiku O, Folorunso S, Omoyiola O, Aderounmu A, Adisa A, Kingham P, Alatise O. Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry. Journal Of Surgical Oncology 2024, 131: 630-636. PMID: 39558548, DOI: 10.1002/jso.27993.Peer-Reviewed Original ResearchInstitutional cancer registryGastric cancerCancer RegistryTreatment modalitiesSuspected gastric cancerManagement of gastric cancerQuality of registry dataTertiary referral centerGastric cancer registryHigh-risk patientsDatabase of patientsGastric cancer databasePeriodic chart reviewMetastatic diseaseAdvanced diseaseReferral centerCancer DatabaseAvailability of robust dataMedian timeChart reviewFollow-upDeadly malignancyBlood workPatientsRegistry dataTargeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit
Kume K, Iida M, Iwaya T, Yashima-Abo A, Koizumi Y, Endo A, Wade K, Hiraki H, Calvert V, Wulfkuhle J, Espina V, Siwak D, Lu Y, Takemoto K, Suzuki Y, Sasaki Y, Tokino T, Petricoin E, Liotta L, Mills G, Nishizuka S. Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit. Molecular & Cellular Proteomics 2024, 23: 100870. PMID: 39461475, PMCID: PMC11621936, DOI: 10.1016/j.mcpro.2024.100870.Peer-Reviewed Original ResearchDNA-damaging drugsTotal lymphocyte countCell linesResistance to DNA damaging drugsPD-L1Adjuvant chemotherapyProtein dynamicsProtein-level regulationSurvival benefitCopy number lossExpression time courseGastric cancerRelapse-free survival rateGastric cancer cellsHost immunityAssociated with prolonged survivalIncreased STAT1 phosphorylationResistance to other drugsGlobal protein dynamicsImmune checkpoint blockadePD-L1 positivityPD-L1 expressionAdvanced gastric cancerExpression of STAT1Molecular targeted drugs1418P Tumor microenvironment B-cell abundance and survival in resectable gastric cancer: A translational analysis from the CLASSIC trial
Sachdeva M, Tay R, KIM Y, Kim H, Cheong J, Grabsch H, Sundar R. 1418P Tumor microenvironment B-cell abundance and survival in resectable gastric cancer: A translational analysis from the CLASSIC trial. Annals Of Oncology 2024, 35: s885. DOI: 10.1016/j.annonc.2024.08.1484.Peer-Reviewed Original ResearchFoundational Models for Pathology and Endoscopy Images: Application for Gastric Inflammation
Kerdegari H, Higgins K, Veselkov D, Laponogov I, Polaka I, Coimbra M, Pescino A, Leja M, Dinis-Ribeiro M, Kanonnikoff T, Veselkov K. Foundational Models for Pathology and Endoscopy Images: Application for Gastric Inflammation. Diagnostics 2024, 14: 1912. PMID: 39272697, PMCID: PMC11394237, DOI: 10.3390/diagnostics14171912.Peer-Reviewed Original ResearchUpper gastrointestinal (GI) cancerIntestinal metaplasiaGastric cancerGastrointestinal (GI) cancersImprove patient outcomesAccuracy of endoscopyCancer mortalityGlobal cancer mortalityArtificial intelligencePatient outcomesGC casesChronic inflammationRegular surveillanceGastric inflammationDeep learning modelsClinical practiceIntegration of artificial intelligenceIntegration of multimodal dataLarge-scale dataPathology image analysisEndoscopyCancerEarly detectionMultimodal dataPathologySpatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases
Zhao J, Ong C, Srivastava S, Chia D, Ma H, Huang K, Sheng T, Ramnarayanan K, Ong X, Tay S, Hagihara T, Tan A, Teo M, Tan Q, Ng G, Tan J, Ng M, Gwee Y, Walsh R, Law J, Shabbir A, Kim G, Tay Y, Her Z, Leoncini G, Teh B, Hong J, Tay R, Teo C, Dings M, Bijlsma M, Lum J, Mathur S, Pietrantonio F, Blum S, van Laarhoven H, Klempner S, Yong W, So J, Chen Q, Tan P, Sundar R. Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases. Gastroenterology 2024, 167: 1384-1398.e4. PMID: 39147169, DOI: 10.1053/j.gastro.2024.08.007.Peer-Reviewed Original ResearchPeritoneal metastasisTumor microenvironmentPrimary tumorTranscoelomic metastasisGastric cancerExpression of therapeutic targetsAssociated with poor prognosisGastric cancer peritoneal metastasisAssociated with increased riskHumanized mouse modelTherapeutic targetComprehensive multi-omics analysisTumor microenvironment signaturesTumor microenvironment alterationsDigital spatial profilingInvestigate molecular alterationsWhole-exome sequencingMatched normal tissuesStromal infiltrationComprehensive molecular characterizationLiver metastasesImmune compositionFGFR2b expressionImprove patient outcomesPredictive markerPrecision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
Yu Y, Zhang Z, Zhu M, Shan Y, Wang Y, Wei L, Huang X, Sun D, Peng Z, Liu T. Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer. Clinical And Translational Discovery 2024, 4 DOI: 10.1002/ctd2.350.Peer-Reviewed Original ResearchSingle nucleotide variantsCopy number variationsGenomic featuresMET amplificationOverall survivalCohort 1TCGA cohortMesenchymal-epithelial transitionGastric cancerSignificant copy number variationsCohort 2Nucleotide variantsPI3K pathwayCancer Genome AtlasNumber variationsRNA dataExpression analysisMutational landscapeProgression-FreeClinical responseK pathwayMET therapyChinese patientsKaplan-MeierTreated patientsA nomogram combining neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) to predict distant metastasis in gastric cancer
Liu J, Sun R, Cai K, Xu Y, Yuan W. A nomogram combining neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) to predict distant metastasis in gastric cancer. Scientific Reports 2024, 14: 15391. PMID: 38965325, PMCID: PMC11224267, DOI: 10.1038/s41598-024-65307-7.Peer-Reviewed Original ResearchConceptsNeutrophil-to-lymphocyte ratioPrognostic nutritional indexPlatelet-to-lymphocyte ratioSystemic immune-inflammatory indexLymphocyte to monocyte ratioMultivariate logistic regression analysisDistant metastasisLogistic regression analysisLymphocyte ratioReceiver Operating CharacteristicGastric cancerValidation cohortPredictive factorsRisk factors of distant metastasisDistant metastasis of gastric cancerNutritional indexImmune-inflammatory indexClinical practiceNomogram's predictive performanceDecision curve analysisGastric cancer patientsMetastasis of gastric cancerEfficient nomogramRegression analysisMonocyte ratioDevelopment and validation of an individualized nomogram for gastric cancer patients treated with perioperative chemotherapy followed by radical surgery
Wang Y, Zhang S, Ding B, Tang Z, Ji Y, Yu Y, Cui Y, Wang X, Sun Y, Liu T. Development and validation of an individualized nomogram for gastric cancer patients treated with perioperative chemotherapy followed by radical surgery. Translational Gastroenterology And Hepatology 2024, 0: 0-0. PMID: 39091661, PMCID: PMC11292059, DOI: 10.21037/tgh-23-75.Peer-Reviewed Original ResearchLocally advanced GC patientsProgression-free survivalAdvanced GC patientsOverall survivalDecision curve analysisTumor-node-metastasisRadical surgeryGC patientsReceiver Operating CharacteristicNeoadjuvant chemotherapyPerioperative chemotherapyPrognostic factorsStaging systemC-indexTumor-node-metastasis (TNM) staging systemGastric cancerLocally advanced gastric cancerPatients treated with perioperative chemotherapyMultivariate Cox regression modelAssociated with clinical characteristicsAdvanced gastric cancerRisk group classificationExternal validation cohortIndependent external cohortLow-risk groupHERTHENA-PanTumor01: A global, multicohort, phase 2 trial of HER3-DXd in relapsed/refractory metastatic solid tumors.
Bhatia A, Hayashi H, Kogawa T, Nishina T, Fountzilas C, Castillo D, McKean M, Colombo N, Smithy J, Fayette J, Chandra S, Powles T, Kudchadkar R, Sternberg D, Sullivan K, Yueh S, Clinthorne G, Burtness B. HERTHENA-PanTumor01: A global, multicohort, phase 2 trial of HER3-DXd in relapsed/refractory metastatic solid tumors. Journal Of Clinical Oncology 2024, 42: tps3164-tps3164. DOI: 10.1200/jco.2024.42.16_suppl.tps3164.Peer-Reviewed Original ResearchHead and neck squamous cell cancerHuman epidermal growth factor receptor 3Platinum-based chemotherapyHER3-DXdPhase 2 trialAntibody-drug conjugatesSolid tumorsHuman anti-HER3 monoclonal antibodyAnti-HER3 monoclonal antibodyAnti-PD-(L)1 therapyGastric cancerHER2-negative gastric cancerTopoisomerase I inhibitor payloadAssociated with poor clinical outcomesEpidermal growth factor receptor 3Anti-HER3 antibodiesGastroesophageal junction cancerHER2+ cancersMetastatic solid tumorsMetastatic breast cancerSquamous cell cancerBRAF wild-typePoor clinical outcomesMultiple tumor typesAcral subtypeThe protective effect of dietary folate intake on gastric cancer is modified by alcohol consumption: A pooled analysis of the StoP Consortium
Gonzalez‐Palacios S, Compañ‐Gabucio L, Torres‐Collado L, Oncina‐Canovas A, García‐de‐la‐Hera M, Collatuzzo G, Negri E, Pelucchi C, Rota M, López‐Carrillo L, Lunet N, Morais S, Ward M, Martin V, Lozano‐Lorca M, Malekzadeh R, Pakseresht M, Hernández‐Ramírez R, Bonzi R, Patel L, López‐Cervantes M, Rabkin C, Tsugane S, Hidaka A, Trichopoulou A, Karakatsani A, Camargo M, Curado M, Zhang Z, La Vecchia C, Boffetta P, Vioque J. The protective effect of dietary folate intake on gastric cancer is modified by alcohol consumption: A pooled analysis of the StoP Consortium. International Journal Of Cancer 2024, 155: 1367-1375. PMID: 38757245, PMCID: PMC11326987, DOI: 10.1002/ijc.35004.Peer-Reviewed Original ResearchDietary folate intakeHigh folate intakeFolate intakeRisk of GCOdds ratioGastric cancerAlcoholic drinks/dayAlcohol consumptionEffect of dietary folate intakeEffect of folate intakeQuartile of folate intakeFood frequency questionnaireCalculate adjusted odds ratiosCase-control studyConfidence intervalsAdjusted odds ratiosFrequency questionnaireGC casesGC riskPooled analysisQuartile incrementLowest quartileLow riskLinear mixed modelsModifiable factors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply